人工内耳の世界市場-2022-2029年

市場力学

人工内耳の世界市場は、高齢者人口の増加や利便性向上のための技術進歩などの要因によって成長しています。

技術的な進歩や人工内耳のバッテリー寿命の向上は、市場の成長を促進すると予想されます。

高齢者人口の増加は、そのうちの約3分の1が難聴の影響を受けており、世界的に人工内耳市場の成長を後押しする主要因の1つとなっています。例えば、米国国勢調査局によると、世界の約8.5％、すなわち6億1700万人が65歳以上の難聴を患っています。また、世界保健機関（WHO）の報告書2019によると、世界全体で約4億6600万人が障害を伴う難聴を患っているとのことです。2050年には9億人以上の人が、障害を伴う難聴になると推測されています。約11億人の若者（12～35歳）が、レクリエーションの場で騒音にさらされることにより、難聴の危険にさらされています。

米国疾病対策予防センター（CDC）によると、2025年までに推定9億人の患者が重度の聴覚障害に苦しむ可能性があるといいます。また、人工内耳や補聴器などの聴覚機器の使用によって恩恵を受ける可能性のある人は、およそ7200万人いるとされています。したがって、聴覚障害の増加が補聴器に対する需要を高めています。

また、人工内耳の技術的進歩が進むことで、より正確に信号を伝達し、電池寿命を延ばすためのデバイスが強化されています。複数のメーカーが、人工内耳の品質とデザインの向上に取り組んでいます。FDA承認のNucleus 7 Sound Processorは、iPhone、iPod、iPadでの使用に特化して作られた、初の人工内耳サウンドソリューションです。また、現在市販されている耳かけ型人工内耳の中で、最も小型・軽量であることも特徴です。

人工内耳は、高コストでメンテナンスが必要なため、市場成長の妨げになることが予想されます。

手術に伴うリスク、人工内耳の承認待ちの期間、人工内耳の高額な費用、メンテナンスの難しさなどが、市場の成長を阻害する要因のひとつとなっています。

産業分析

人工内耳の世界市場は、ポーターのファイブフォース、規制分析、サプライチェーン分析、価格分析、製品イノベーション、アンメットニーズなどの様々な業界要因に基づいて、市場の詳細な分析を提供しています。

人工内耳の世界市場レポートでは、約45+市場データ表、40+図、180ページへのアクセスを提供します。

目次

第1章 調査手法と調査範囲

• 調査手法
• 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場の力学

• 市場影響要因
  • 促進要因
    • 老年人口における聴覚障害の増加
    • 人工内耳の技術的進歩および電池寿命の向上
  • 抑制要因
    • 機器とメンテナンスのコストが高い
    • 手術別怪我のリスク
  • ビジネスチャンス
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• 規制分析
• サプライチェーン分析
• プライシング分析
• 製品イノベーション
• アンメットニーズ

第6章 タイプ別

• 片側インプラント
• 両側性インプラント

第7章 エンドユーザー別

• 小児科
• 成人

第8章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第9章 競合情勢

• 主な展開と戦略
• 企業シェア分析
• タイプ別ベンチマーク
• 注目の主要企業リスト

第10章 企業プロファイル

• Cochlear Ltd.
  • 企業概要
  • タイプ別ポートフォリオと説明
  • 主なハイライト
  • 財務概要
• MED-EL GmbH
• Oticon Medical AB
• Advanced Bionics AG
• Demant A/S
• Sonova Holding AG
• Nurotron Biotechnology Co Ltd

第11章 人工内耳の世界市場-DataM

Market Overview

Cochlear Implants Market size was valued US$ 1.4 billion in 2021 and is estimated to reach US$ 2.5 billion by 2029, growing at a CAGR of 7.4% during the forecast period (2022-2029).

A cochlear implant is an electronic device that is surgically implanted that stimulates the cochlear nerve and restores the sense of hearing through transmitting the electrical signals to the brain. People mostly use these implants as a hearing aid with low to high hearing loss.

These cochlear implants consist of two parts, the inside component is embedded across the skin, and the external component is worn at the back of the ear. These implants bypass the non-functioning part of the inner ear and provide electrical stimulation to the nerve fibres present in the cochlea.

Market Dynamics

The global cochlear implant market is growing owing to several factors such as the rising geriatric population, technological advancements in devices to make them convenient for use.

Rising technological advancements and increased battery life of cochlear is expected to drive market growth.

The growing geriatric population, of which approximately one-third of people are affected by disabling hearing loss, is one of the major factors boosting the growth of the cochlear implants market globally. For instance, according to the U.S. Census Bureau, about 8.5% of people worldwide, i.e., 617 million were over age 65 were suffering from hearing loss. Also, according to the World Health Organization (WHO) report 2019, about 466 million people are having disabling hearing loss globally. It is estimated that over 900 million people will have disabling hearing loss by 2050. About 1.1 billion young people (age between 12-35 years) are at risk of hearing loss, owing to exposure to noise in recreational settings.

According to the Centres for Disease Control and Prevention (CDC), an estimated 900 million patients are likely to suffer from severe hearing impairment by 2025. There are approximately 72 million people who could potentially benefit from the use of a hearing device, including a cochlear implant or hearing aid. Hence, rising hearing disorders have increased the demand for hearing aid devices.

Also, the increasing technological advancements in cochlear implants are enhancing the devices to transfer signals more accurately and increase their battery life. Several manufacturers are involved in improving the quality and design of cochlear implants. The FDA-approved Nucleus 7 Sound Processor is the first cochlear implant sound solution made specifically for use with iPhones, iPods, and iPads. It also has the distinction of being the smallest and lightest behind-the-ear cochlear implant currently on the market.

High cost of the device and maintenance is expected to hamper the market growth.

Factors such the risk related to surgery, long awaiting approvals for cochlear implants, the high cost of cochlear implants and difficulty in maintenance are some of the factors hampering the growth of the market.

Industry Analysis

The global cochlear implants market provides in-depth analysis of the market based on various industry factors such as Porter's Five Forces, Regulatory Analysis, Supply Chain Analysis, Pricing Analysis, Product Innovation, Unmet Needs.

Segment Analysis

Bilateral implants segment is expected to hold the largest market share in global cochlear implants market

By type, the cochlear implants market is segmented into unilateral implants and bilateral implants. Among these, unilateral implants accounted for the largest market share, owing to their high demand globally. Unilateral implants are of lower cost compared to bilateral implants. According to some studies, the unilateral cochlear implant is more cost-effective for adults and has several health benefits.

On the other hand, the bilateral implants segment is estimated to grow at the fastest CAGR over the forecast period, owing to its ability to recognize the speech in noise, cost-effectiveness when implanted in children, and rising meningitis cases. Also, some countries offer reimbursement only after bilateral implantation, thus, increases the demand for these devices.

Geographical Analysis

North America region holds the largest market share in the global cochlear implants market

North America is dominating the global cochlear implant market accounted for the largest market share, owing to the developed healthcare system, better awareness among the people, and the presence of major market players in this region. The prevalence of hearing loss in the U.S. affects around 10.6 percent of the population, compared to 12.1 percent of the population in Germany and eight percent of those in Switzerland. According to Johns Hopkins Cochlear Center for Hearing and Public Health, approximately 38.2 million Americans (14.3%) report some degree of hearing loss.

According to the National Institute on Deafness and Other Communication Disorders, approximately one in three people in the United States between the ages of 65 and 74 have hearing loss, and nearly half of those older than 75 have difficulty hearing. The number of adults in the United States above 20 years of age with hearing loss is expected to increase from the expected 44.11 million in 2020 to 73.50 million in 2060. The increase is greater in older adults with an expected 55.4% of the US population above 70 years to suffer from hearing loss to 67.4% in 2060. The development of technologically advanced implants is boosting the growth of the market in this region. For instance, in April 2019, Advanced Bionics received approval from Health Canada for its HiRes Ultra 3D Cochlear Implant. The implant is a pain-free and hassle-free choice for patients undergoing MRI examinations.

Competitive Landscape

The global cochlear implants market is consolidated comprises only a few major players. Most of the major players are based in the US and Europe, as these regions are more developed and better funded for healthcare. Some of the major players in the market include Cochlear Ltd, MED-EL Medical Electronics, Oticon Medical, Advanced Bionics AG, Demant A/S, Sonova, Nurotron Biotechnology Co Ltd, among others.

The key players are adopting various growth strategies such as expansion, mergers & acquisitions, partnerships, product launches, and collaborations which are contributing to the growth of the Cochlear Implant market globally. For instance,

On July 22nd, 2019, MED-EL USA received the U.S. Food and Drug Administration (FDA) approval for its cochlear implant system for single-sided deafness (SSD) and asymmetric hearing loss (AHL). This is the first and only time that cochlear implants have been approved for these indications in the United States.

Key Companies to Watch

Cochlear Ltd.:

Overview: Cochlear is an Australia based medical device company which develops and markets variety of implants such as Nucleus cochlear implant, Baha bona conduction implants and hybrid electro-acoustic implants. It was founded in 1981, headquartered in Sydney, Australia.

Product Portfolio:

Nucleus 24 Cochlear Implant System: This is an implant that impart some hearing sensation to the user via electrical stimulation of auditory nerve. It contains 2 components, internal and external.

Key Developments: In 2019, Cochlear announced world's 1st active osseo-integrated steady state implant, Osia. It utilizes digital piezoelectric stimulation that bypass the damaged areas of hearing system by which sound vibrations directly reaches to cochlea.

The global cochlear implants market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

The companies such as Cochlear and Sensorion evaluates SENS-401 with a cochlear's implant. Cochlear invested about USD 1.8 million (€1.6 million) in shares of Sensorion as a part of this collaboration. In exchange, Cochlear would receive a right of first negotiation for a global license of SENS-401 in patients along with specific cochlear devices.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers:
    • 4.1.1.1. Growing hearing impairment in geriatric population
    • 4.1.1.2. Rising technological advancements and increased battery life of cochlear implants
  • 4.1.2. Restraints:
    • 4.1.2.1. High cost of the device and maintenance
    • 4.1.2.2. Risk of injuries in surgery
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Regulatory Analysis
• 5.3. Supply Chain Analysis
• 5.4. Pricing Analysis
• 5.5. Product Innovations
• 5.6. Unmet Needs

6. By Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
  • 6.1.2. Market Attractiveness Index, By Type Segment
• 6.2. Unilateral Implantation
  • 6.2.1.1. Introduction
  • 6.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 6.3. Bilateral Implantation

7. By End User

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
  • 7.1.2. Market Attractiveness Index, By End User Segment
• 7.2. Pediatrics
  • 7.2.1.1. Introduction
  • 7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Adults

8. By Region

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 8.1.2. Market Attractiveness Index, By Region
• 8.2. North America
  • 8.2.1. Introduction
  • 8.2.2. Key Region-Specific Dynamics
  • 8.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 8.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 8.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 8.2.5.1. U.S.
    • 8.2.5.2. Canada
    • 8.2.5.3. Mexico
• 8.3. Europe
  • 8.3.1. Introduction
  • 8.3.2. Key Region-Specific Dynamics
  • 8.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 8.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 8.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 8.3.5.1. Germany
    • 8.3.5.2. U.K.
    • 8.3.5.3. France
    • 8.3.5.4. Italy
    • 8.3.5.5. Spain
    • 8.3.5.6. Rest of Europe
• 8.4. South America
  • 8.4.1. Introduction
  • 8.4.2. Key Region-Specific Dynamics
  • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 8.4.5.1. Brazil
    • 8.4.5.2. Argentina
    • 8.4.5.3. Rest of South America
• 8.5. Asia Pacific
  • 8.5.1. Introduction
  • 8.5.2. Key Region-Specific Dynamics
  • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 8.5.5.1. China
    • 8.5.5.2. India
    • 8.5.5.3. Japan
    • 8.5.5.4. Australia
    • 8.5.5.5. Rest of Asia Pacific
• 8.6. Middle East and Africa
  • 8.6.1. Introduction
  • 8.6.2. Key Region-Specific Dynamics
  • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

9. Competitive Landscape

• 9.1. Key Developments and Strategies
• 9.2. Company Share Analysis
• 9.3. Type Types Benchmarking
• 9.4. List of Key Companies to Watch

10. Company Profiles

• 10.1. Cochlear Ltd.
  • 10.1.1. Company Overview
  • 10.1.2. Type Type Portfolio and Description
  • 10.1.3. Key Highlights
  • 10.1.4. Financial Overview
• 10.2. MED-EL GmbH
• 10.3. Oticon Medical AB
• 10.4. Advanced Bionics AG
• 10.5. Demant A/S
• 10.6. Sonova Holding AG
• 10.7. Nurotron Biotechnology Co Ltd

LIST NOT EXHAUSTIVE

11. Global Cochlear Implants Market - DataM

• 11.1. Appendix
• 11.2. About Us and End User
• 11.3. Contact Us